Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.

about

Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.

P2860

Q50052885-CB512831-15AF-4781-80E7-CC4C3B2268D8

P2860

Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.

Item

http://www.wikidata.org/entity/Q38663444

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinical and economic burden o ...... oms in a managed care setting.

@en

type

Item

label

Clinical and economic burden o ...... oms in a managed care setting.

@en

prefLabel

Clinical and economic burden o ...... oms in a managed care setting.

@en

P1476

Clinical and economic burden o ...... oms in a managed care setting.

@en

P2093

Anand A Dalal

http://www.w3.org/2001/XMLSchema#string

Debra Wertz

http://www.w3.org/2001/XMLSchema#string

Jeetvan Patel

http://www.w3.org/2001/XMLSchema#string

Judith J Stephenson

http://www.w3.org/2001/XMLSchema#string

Tao Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Development, validity and responsiveness of the Clinical COPD Questionnaire

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study

Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care

Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease

Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.

The MRC breathlessness scale.

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009.

P304

1947-1959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S134618

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740375

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5503502

http://www.w3.org/2001/XMLSchema#string

Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.

about

P2860

P2860

Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932